1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grants2027-2029 Requests for Proposals (Older Americans Act Services) is sponsored by Region IV Area Agency on Aging (Michigan). Region IV AAA provides state and federal funding for community-based services through an open and competitive Request for Proposals (RFP) process every three years.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Non-profit organizations, private for-profit entities, or government agencies that can comply with Bureau of Aging, Community Living, & Supports Operating Standards and provide services to older adults and caregivers in Berrien, Cass, and Van Buren counties. Confirm the full requirements in the official notice before applying.
2027-2029 Requests for Proposals (Older Americans Act Services) is funded by Region IV Area Agency on Aging (Michigan). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Michigan. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article